Finance

Lists
Q3 2026 earnings • released • EPS beat +28.67% • Revenue beat +1.81%
See results
CURA:TSE
Curaleaf Holdings Inc
CA$13.23
+0.08%
(+0.0100) 1D
Nov 6, 4:00:00 PM GMT-5  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for CURA...
Open
CA$13.28
High
CA$13.71
Low
CA$13.18
Mkt. cap
3.10B
Avg. vol.
317.07K
Volume
337.97K
52-wk high
CA$20.92
52-wk low
CA$7.77
EPS
-CA$0.06
Shares outstanding
233.67M
No. of employees
6K
Open
CA$13.28
High
CA$13.71
Low
CA$13.18
Mkt. cap
3.10B
Avg. vol.
317.07K
Volume
337.97K
52-wk high
CA$20.92
52-wk low
CA$7.77
EPS
-CA$0.06
Shares outstanding
233.67M
No. of employees
6K
News stories
From web sources and news partners
About Curaleaf Holdings Inc
CEO-
Employees5.55K
Founded2014
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitecuraleaf.com
Last report
Nov 4, 2026
Fiscal period
Q3 2026
-$0.11 / -$0.15
+28.67%beat
Revenue / Est. (USD)
352.65M / 346.39M
+1.81%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
323.36M
324.23M
340.10M
352.65M
Cost of goods sold
159.81M
166.94M
170.18M
182.17M
Cost of revenue
159.81M
166.94M
170.18M
182.17M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
105.76M
113.21M
131.68M
131.03M
Operating expense
153.25M
156.54M
165.69M
167.53M
Total operating expenses
313.06M
323.48M
335.88M
349.71M
Operating income
10.31M
753.00K
4.22M
2.94M
Other non operating income
2.84M
1.23M
1.51M
2.44M
EBT including unusual items
-16.74M
-28.63M
-26.31M
-22.86M
EBT excluding unusual items
-11.25M
-24.88M
-24.51M
-22.88M
Income tax expense
25.22M
-98.70M
-38.78M
14.51M
Effective tax rate
-150.58%
344.77%
147.42%
-63.48%
Other operating expenses
-
-
-
-
Net income
-59.82M
69.80M
12.51M
-32.72M
Net profit margin
-18.50%
21.53%
3.68%
-9.28%
Earnings per share
-0.15
0.29
0.07
-0.11
Interest and investment income
174.00K
212.00K
149.00K
121.00K
Interest expense
-24.50M
-25.53M
-27.72M
-28.39M
Net interest expenses
-24.32M
-25.32M
-27.57M
-28.27M
Depreciation and amortization charges
35.14M
33.67M
34.02M
36.51M
EBITDA
58.37M
48.61M
52.83M
51.56M
Gain or loss from assets sale
499.00K
-194.00K
194.00K
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps